Kranzler Jay D's Form 4 filing
Avenue Therapeutics, Inc. (ATXI) · filed Oct 1, 2024
- Accession no.
- 0001104659-24-104931
- Filed
- Oct 1, 2024
- Trade date
- Sep 27-30, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $1.25K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kranzler Jay DCIK 0001055666 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | COMMON STOCK, PAR VALUE $0.0001 | PPurchaseAcquired | +3 | $2.40 | +$7.2 | 123 | Direct | |
| Sep 30, 2024 | COMMON STOCK, PAR VALUE $0.0001 | PPurchaseAcquired | +497 | $2.50 | +$1,242.5 | 620 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.